시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 원격 채혈 건조 혈액 기기 시장 보고서(2025년)
Remote Blood-Draw Dried-Spot Device Global Market Report 2025
상품코드 : 1877869
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,668,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,638,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,609,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

원격 채혈 건조 혈액 기기 시장 규모는 최근 급속히 확대되고 있습니다. 2024년 8억 1,000만 달러로 평가되었고, 2025년에는 9억 2,000만 달러, CAGR 13.7%로 성장할 것으로 전망되고 있습니다. 지난 몇 년간의 성장은 원격 환자 모니터링의 도입 확대, 만성 질환 증가, 재택 진단 솔루션에 대한 인지도 향상, 재택치료 서비스의 확충, 저침습 검사에 대한 수요 증가 등이 요인으로 생각됩니다.

원격 채혈 건조 혈액 기기 시장 규모는 앞으로 몇 년 동안 급속한 성장이 예상됩니다. 2029년에는 15억 3,000만 달러에 이르고, CAGR은 13.3%를 나타낼 전망입니다. 예측기간 동안의 성장요인으로는 인공지능(AI)과 디지털 툴의 통합 진전, 맞춤형 의료에 대한 주목 증가, 의료 액세스 향상을 위한 정부 주도 노력 증가, 원격 의료 네트워크의 확대, 진단 스타트업 기업에 대한 자금 조달 증가 등이 있습니다. 예측 기간 동안의 주요 동향에는 마이크로플루이딕스 기술의 발전, 바이오센서 설계 혁신, 자동화 및 로봇 공학 분야의 발전, 데이터 분석 통합의 발전, 환자 중심 기기 인터페이스의 혁신이 포함됩니다.

맞춤형 의료에 대한 관심 증가는 향후 몇 년 동안 원격 채혈 건조 혈액 기기 시장 성장을 이끌 것으로 예측됩니다. 맞춤형 의료는 개인의 고유한 유전적, 분자적, 임상적 특성에 기초하여 의료 치료 및 예방 전략을 조정하고 더 나은 건강 성과를 달성하는 것입니다. 유전체학의 진보에 의해 질병 감수성이나 치료 반응에 영향을 주는 유전적 변이를 특정하는 것이 가능하게 되어, 보다 표적을 좁힌 효과적인 치료법을 실현할 수 있게 되었기 때문에 맞춤형 의료의 도입이 증가하고 있습니다. 원격 채혈 건조 혈액 기기는 소량의 혈액 샘플을 집에서 쉽게 채취할 수 있으므로 바이오마커와 유전 정보의 빈번한 모니터링을 가능하게 하고, 맞춤 치료 판단을 지원함으로써 이 접근법을 지원합니다. 예를 들어 미국 비영리 단체인 '맞춤형 의료연합'에 따르면 2024년 2월 시점에서 FDA는 2023년 희소질환 환자를 위한 신규 맞춤형 치료 16건을 승인했습니다. 이것은 2022년 6건에서 증가한 수치입니다. 승인 내용에는 암 치료 7건과 기타 질환용 3건이 포함되어 있습니다. 이와 같이 맞춤형 의료에 대한 주목도가 높아지고 있는 것이, 원격 채혈 건조 혈액 기기 시장의 성장을 견인하고 있습니다.

원격 채혈 건조 혈액 기기 시장의 주요 기업은 가정에서의 채혈을 가능하게 하고 환자의 편의성을 높이고 임상시험의 효율성을 향상시키는 첨단 분산형 샘플링 솔루션을 개발하고 있습니다. 분산형 샘플링이란, 종래의 임상 환경(의료기관) 이외(자택이나 지역 시설 등)에서 생체 샘플을 채취하는 수법으로, 보다 광범위한 참가자의 확보, 신속한 샘플 처리, 데이터 액세스의 향상을 실현합니다. 예를 들어, 2025년 3월, 미국 의료 기술 기업인 Tasso는 임상시험 및 스포츠 도핑 검사를 위해 설계된 차세대 건조 혈액 스폿(DBS) 샘플링 기술을 도입했습니다. 이 혁신적인 기술은 거의 무통하고 정확하고 사용자 친화적 인 채혈 방법을 제공하여 정밀한 볼륨 샘플링과 고품질 데이터 생성을 가능하게합니다. 샘플링 프로세스의 간소화와 참가 장벽의 저감에 의해 컴플라이언스의 향상, 의약품 개발의 가속, 분산형 의료·연구 모델의 지원을 실현합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

SHW
영문 목차

영문목차

A remote blood draw dried spot device is a medical tool used to collect small blood samples from patients remotely, often in home settings, by applying the blood onto specialized filter paper or absorbent material. The collected dried blood spots can then be safely transported to a laboratory for testing, allowing convenient monitoring of health parameters without the need for traditional venous blood draws.

The main product types of remote blood draw dried spot devices include filter paper devices, microfluidic devices, and others. Filter paper devices are designed to collect and preserve small blood samples on treated paper, providing a convenient, stable, and easily transportable method for dried blood spot testing. The supported sample types include whole blood, plasma, serum, and others, and these products are distributed through direct sales, online retail, pharmacies, and other channels. They are used in various applications such as disease diagnosis, therapeutic drug monitoring, newborn screening, forensic testing, and others, and serve end users including hospitals and clinics, diagnostic laboratories, research institutes, home care settings, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The remote blood-draw dried-spot device market research report is one of a series of new reports from The Business Research Company that provides remote blood-draw dried-spot device market statistics, including remote blood-draw dried-spot device industry global market size, regional shares, competitors with a remote blood-draw dried-spot device market share, detailed remote blood-draw dried-spot device market segments, market trends and opportunities, and any further data you may need to thrive in the remote blood-draw dried-spot device industry. This remote blood-draw dried-spot device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The remote blood-draw dried-spot device market size has grown rapidly in recent years. It will grow from $0.81 billion in 2024 to $0.92 billion in 2025 at a compound annual growth rate (CAGR) of 13.7%. The growth during the historic period can be attributed to the rising adoption of remote patient monitoring, the increasing prevalence of chronic diseases, the growing awareness of at-home diagnostic solutions, the expansion of home healthcare services, and the increasing demand for minimally invasive testing.

The remote blood-draw dried-spot device market size is expected to see rapid growth in the next few years. It will grow to $1.53 billion in 2029 at a compound annual growth rate (CAGR) of 13.3%. The growth during the forecast period can be attributed to the rising integration of artificial intelligence and digital tools, the growing focus on personalized medicine, the increasing government initiatives to enhance healthcare accessibility, the expansion of telemedicine networks, and the rising funding for diagnostic startups. Major trends during the forecast period include technological advancements in microfluidics, innovations in biosensor design, developments in automation and robotics, progress in data analytics integration, and innovations in patient-centric device interfaces.

The growing emphasis on personalized medicine is expected to drive the growth of the remote blood-draw dried-spot device market in the coming years. Personalized medicine involves tailoring medical treatments and preventive strategies based on an individual's unique genetic, molecular, and clinical characteristics to achieve better health outcomes. The adoption of personalized medicine is increasing as advances in genomics make it possible to identify genetic variations that influence disease susceptibility and treatment response, enabling more targeted and effective therapies. Remote blood-draw dried-spot devices support this approach by allowing convenient, at-home collection of small blood samples, facilitating frequent monitoring of biomarkers and genetic information to guide individualized treatment decisions. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the FDA approved 16 new personalized treatments for rare disease patients in 2023, up from six in 2022. These approvals included seven cancer therapies and three for other conditions. Therefore, the rising focus on personalized medicine is driving the growth of the remote blood-draw dried-spot device market.

Major companies in the remote blood-draw dried-spot device market are developing advanced decentralized sampling solutions to enable at-home blood collection, enhance patient convenience, and improve clinical trial efficiency. Decentralized sampling involves collecting biological samples outside traditional clinical settings, such as at home or in local facilities, allowing broader participation, faster sample turnaround, and improved data accessibility. For example, in March 2025, Tasso Inc., a US-based healthcare technology company, introduced next-generation dried blood spot (DBS) sampling technology designed for clinical trials and sports anti-doping testing. This innovation provides a virtually painless, accurate, and user-friendly method for blood collection, enabling precise volumetric sampling and high-quality data generation. By simplifying the sampling process and reducing participation barriers, the technology enhances compliance, accelerates drug development, and supports decentralized healthcare and research models.

In April 2025, Boston, a US-based biotechnology company, partnered with Nanowear Inc. to develop advanced wearable biosensors for continuous health monitoring. The collaboration aims to transform home-based healthcare by integrating AI-powered nanotechnology diagnostics with blood-based sampling and drug delivery patches. This combined digital health platform enables precise, continuous, and patient-friendly diagnostics and therapeutics, promoting the shift from clinic-centered to decentralized personalized care. Nanowear Inc., a US-based technology company, offers remote blood-draw dried-spot devices that complement these innovations in wearable biosensing and digital health monitoring.

Major players in the remote blood-draw dried-spot device market are DBS System SA, Labcorp Holdings, Thorne HealthTech Inc., Trajan Scientific and Medical Pty Ltd., Salimetrics LLC, Tasso Inc., Lipomic Healthcare Inc., Neoteryx Inc., Salimetrics LLC, Eastern Business Forms Inc., Ash Wellness Inc., Capitainer AB, Drawbridge Health Inc., HemaXis S.A., ImmunoServ Ltd., Labonovum BV, PanoHealth Inc., RedDrop Dx Inc., Nightingale Health Plc, Spot On Sciences Inc., and RDA Spot Inc.

North America was the largest region in the remote blood-draw dried-spot device market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in remote blood-draw dried-spot device report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the remote blood-draw dried-spot device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The remote blood-draw dried-spot device market consists of sales of capillary blood collection kits, prepaid sample mailers, and integrated smart collection devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Remote Blood-Draw Dried-Spot Device Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on remote blood-draw dried-spot device market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for remote blood-draw dried-spot device ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The remote blood-draw dried-spot device market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Remote Blood-Draw Dried-Spot Device Market Characteristics

3. Remote Blood-Draw Dried-Spot Device Market Trends And Strategies

4. Remote Blood-Draw Dried-Spot Device Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Remote Blood-Draw Dried-Spot Device Growth Analysis And Strategic Analysis Framework

6. Remote Blood-Draw Dried-Spot Device Market Segmentation

7. Remote Blood-Draw Dried-Spot Device Market Regional And Country Analysis

8. Asia-Pacific Remote Blood-Draw Dried-Spot Device Market

9. China Remote Blood-Draw Dried-Spot Device Market

10. India Remote Blood-Draw Dried-Spot Device Market

11. Japan Remote Blood-Draw Dried-Spot Device Market

12. Australia Remote Blood-Draw Dried-Spot Device Market

13. Indonesia Remote Blood-Draw Dried-Spot Device Market

14. South Korea Remote Blood-Draw Dried-Spot Device Market

15. Western Europe Remote Blood-Draw Dried-Spot Device Market

16. UK Remote Blood-Draw Dried-Spot Device Market

17. Germany Remote Blood-Draw Dried-Spot Device Market

18. France Remote Blood-Draw Dried-Spot Device Market

19. Italy Remote Blood-Draw Dried-Spot Device Market

20. Spain Remote Blood-Draw Dried-Spot Device Market

21. Eastern Europe Remote Blood-Draw Dried-Spot Device Market

22. Russia Remote Blood-Draw Dried-Spot Device Market

23. North America Remote Blood-Draw Dried-Spot Device Market

24. USA Remote Blood-Draw Dried-Spot Device Market

25. Canada Remote Blood-Draw Dried-Spot Device Market

26. South America Remote Blood-Draw Dried-Spot Device Market

27. Brazil Remote Blood-Draw Dried-Spot Device Market

28. Middle East Remote Blood-Draw Dried-Spot Device Market

29. Africa Remote Blood-Draw Dried-Spot Device Market

30. Remote Blood-Draw Dried-Spot Device Market Competitive Landscape And Company Profiles

31. Remote Blood-Draw Dried-Spot Device Market Other Major And Innovative Companies

32. Global Remote Blood-Draw Dried-Spot Device Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Remote Blood-Draw Dried-Spot Device Market

34. Recent Developments In The Remote Blood-Draw Dried-Spot Device Market

35. Remote Blood-Draw Dried-Spot Device Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기